Alan J Stolier

Summary

Affiliation: Tulane University
Country: USA

Publications

  1. ncbi Terminal duct lobular units are scarce in the nipple: implications for prophylactic nipple-sparing mastectomy: terminal duct lobular units in the nipple
    Alan J Stolier
    Tulane University Department of Surgery and Omega Hospital, 2525 Severn Ave, New Orleans, LA, USA
    Ann Surg Oncol 15:438-42. 2008
  2. ncbi Technical considerations in nipple-sparing mastectomy: 82 consecutive cases without necrosis
    Alan J Stolier
    Department of Surgery, Tulane University, 2525 Severn Ave, Metairie, New Orleans, LA 70002, USA
    Ann Surg Oncol 15:1341-7. 2008
  3. ncbi Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation
    Alan J Stolier
    Department of Surgery, Louisiana State University, Baton Rouge, Louisiana, USA
    Breast J 10:475-80. 2004
  4. ncbi A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping
    Walter D Blessing
    Department of Surgery, Ochsner Clinic Foundation, New Orleans, LA 70121, USA
    Am J Surg 184:341-5. 2002
  5. ncbi Areola-sparing mastectomy: defining the risks
    Alan J Stolier
    Department of Surgery, Tulane University, Tulane University Cancer Center, New Orleans, LA 70112, USA
    J Am Coll Surg 201:118-24. 2005
  6. ncbi Newly diagnosed breast cancer patients choose bilateral mastectomy over breast-conserving surgery when testing positive for a BRCA1/2 mutation
    Alan J Stolier
    Department of Surgery, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Am Surg 71:1031-3. 2005
  7. ncbi Postlumpectomy Insertion of the MammoSite brachytherapy device using the scar entry technique: initial experience and technical considerations
    Alan J Stolier
    Department of Surgery, Tulane University and the Tulane Cancer Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA
    Breast J 11:199-203. 2005
  8. ncbi Postmastectomy radiation in patients with four or more positive nodes
    Stephania K C Timothy
    Department of Surgery, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
    Am Surg 68:539-44; discussion 544-5. 2002

Collaborators

Detail Information

Publications8

  1. ncbi Terminal duct lobular units are scarce in the nipple: implications for prophylactic nipple-sparing mastectomy: terminal duct lobular units in the nipple
    Alan J Stolier
    Tulane University Department of Surgery and Omega Hospital, 2525 Severn Ave, New Orleans, LA, USA
    Ann Surg Oncol 15:438-42. 2008
    ..There is evidence to suggest that ductal and lobular breast cancer arises in the terminal duct/lobular unit (TDLU). This study was undertaken to determine whether TDLUs exist in the nipple and if so, to what extent...
  2. ncbi Technical considerations in nipple-sparing mastectomy: 82 consecutive cases without necrosis
    Alan J Stolier
    Department of Surgery, Tulane University, 2525 Severn Ave, Metairie, New Orleans, LA 70002, USA
    Ann Surg Oncol 15:1341-7. 2008
    ..As yet, there are no established techniques that are universally applied to NSM. Herein we describe our surgical approach...
  3. ncbi Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation
    Alan J Stolier
    Department of Surgery, Louisiana State University, Baton Rouge, Louisiana, USA
    Breast J 10:475-80. 2004
    ..It also prevents women who would otherwise be candidates for breast preservation from undergoing unnecessary radiation therapy should they chose prophylactic mastectomy in the face of a positive test...
  4. ncbi A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping
    Walter D Blessing
    Department of Surgery, Ochsner Clinic Foundation, New Orleans, LA 70121, USA
    Am J Surg 184:341-5. 2002
    ..CONCLUSIONS: In our initial experience, methylene blue appears to be equivalent to lymphazurin for sentinel node mapping in breast cancer...
  5. ncbi Areola-sparing mastectomy: defining the risks
    Alan J Stolier
    Department of Surgery, Tulane University, Tulane University Cancer Center, New Orleans, LA 70112, USA
    J Am Coll Surg 201:118-24. 2005
  6. ncbi Newly diagnosed breast cancer patients choose bilateral mastectomy over breast-conserving surgery when testing positive for a BRCA1/2 mutation
    Alan J Stolier
    Department of Surgery, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Am Surg 71:1031-3. 2005
    ..The only patient not undergoing bilateral mastectomy was awaiting liver transplant. Women who are candidates for breast-conserving surgery and who test positive for a breast cancer gene mutation choose mastectomy over surveillance...
  7. ncbi Postlumpectomy Insertion of the MammoSite brachytherapy device using the scar entry technique: initial experience and technical considerations
    Alan J Stolier
    Department of Surgery, Tulane University and the Tulane Cancer Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA
    Breast J 11:199-203. 2005
    ..Patients undergoing accelerated partial breast irradiation with the MammoSite inserted using SET had excellent overall cosmetic results. Advantages of the SET over intraoperative placement are presented...
  8. ncbi Postmastectomy radiation in patients with four or more positive nodes
    Stephania K C Timothy
    Department of Surgery, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
    Am Surg 68:539-44; discussion 544-5. 2002
    ..Adding PMR to breast cancer treatment demonstrated no improvement in outcome. Despite limitations of this retrospective study the results strongly support evaluation of PMR by a high-quality randomized prospective trial...